Abbott is the name behind many well-known products.

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from ...

Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching. Here is why his $2 million ...

Recent discussions on X about Abbott Laboratories (ABT) have centered on the company’s latest quarterly earnings and guidance updates. Posts on the platform highlight a mixed reaction to the ...

With a market cap of $189.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, ...

The company reported quarterly sales of $11.46 billion, slightly missing the consensus of $11.80 billion. Sales increased 4.4% on a reported basis, 3% on an organic basis, or 3.8% when excluding COVID ...

"I think this is a little bit of an overreaction. Of course, we are all over this," Ford said. "We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, ...

Abbott Laboratories has a great financial position. The long-term debt/equity ratio is 0.3, while the interest coverage ratio ...

Investing.com - Leerink Partners has lowered its price target on Abbott Laboratories (NYSE:ABT) to $119.00 from $136.00 while maintaining a Market Perform rating, following the company’s ...

Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table encapsulates their recent ratings, offering a ...